What is CorMedix's melinta portfolio — total revenue?

CorMedix (CRMD) reported melinta portfolio — total revenue of $24.41M in Q1 2026.

What does melinta portfolio — total revenue mean?

This metric represents the total gross revenue generated by the specific product portfolio or business segment identified as Melinta. It reflects the aggregate sales performance and market adoption of these therapeutic assets within the company's broader commercial operations. Monitoring this figure helps investors assess the revenue contribution and growth trajectory of this specific business unit.

CorMedix CRMD Melinta Portfolio — Total Revenue

Other product segments

DefenCath

$97.51M+150%

Contract revenue

$5.51M—

Similar metrics at other companies

BMYGrowth Portfolio — Total Revenues

$6.23B+11.9%

RYTMProduct revenue, net — Total revenues

$60.11M+59.4%

TVTXTotal net product sales — Total Revenue

$124.49M+64.1%

GNTXMedical Products — Total Revenue

$353.62K-8.6%

RITMInvestment Portfolio — Total Revenue

$136.12M+29.5%

ARDXProduct sales, net — Total revenues

$93.37M+37.7%

Other financials

Income statement

See full

Revenue$127.4M+226%

Gross profit$115.4M+207%

Operating income$63.7M+216%

Net income$38.6M+87.0%

EPS (diluted)$0.43+43.3%

Balance sheet

See full

Cash & equivalents$179.1M+170%

Total debt$4.3M+729%

Total equity$437.0M+280%

Total assets$815.6M+445%

Cash flow

See full

Operating cash flow$42.4M+115%

CapEx$729.0K+7,190%

Free cash flow$41.7M+111%

Valuation

See full

Market cap$605.65M-34.4%

P/E3.4×—

P/S1.5×-9.6×

Profitability

See full

Gross margin91.9%-3.5pp

Operating margin48.4%—

Net margin45.2%—

FCF margin48.7%+38.8pp

Returns & leverage

See full

Return on equity65.6%—

Debt / equity0×0.0×

Current ratio3×-1.2×

Where this comes from

Reported directly by CorMedix in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about CorMedix's melinta portfolio — total revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CorMedix's melinta portfolio — total revenue?: CorMedix (CRMD) reported melinta portfolio — total revenue of $24.41M in Q1 2026.
What does melinta portfolio — total revenue mean?: This metric represents the total gross revenue generated by the specific product portfolio or business segment identified as Melinta. It reflects the aggregate sales performance and market adoption of these therapeutic assets within the company's broader commercial operations. Monitoring this figure helps investors assess the revenue contribution and growth trajectory of this specific business unit.